Substituted 4-(indazol-3-yl)phenols

Details Substituted 4-(indazol-3-yl)phenols Substituted 4-(indazol-3-yl)phenols

2007-07-10

2007-07-10

Anderson, Rebecca (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S406000, C548S361100

Reexamination Certificate

active

10670646

ABSTRACT:
This invention provides compound of formulae I or II having the structurewhereinR1, R2, R3, R4, R5, R6, R7, R8, R9, and R10are as defined in the specification or a pharmaceutically acceptable salt thereof which are useful for the treatment of the inflammatory component of diseases and are particularly useful in treating atherosclerosis, myocardial infarction, congestive heart failure, inflammatory bowel disease, arthritis, type II diabetes, and autoimmune diseases such as multiple sclerosis and rheumatiod arthritis.

REFERENCES:
patent: 5856503 (1999-01-01), Aebi et al.
patent: 2002/0103229 (2002-08-01), Bhagwat et al.
patent: 2006/0030612 (2006-02-01), Steffan et al.
patent: 0470039 (1992-02-01), None
patent: 0778271 (1997-06-01), None
patent: 1 380 576 (2004-01-01), None
patent: 01180878 (1988-01-01), None
patent: 02007066 (1988-06-01), None
patent: 01-180878 (1989-07-01), None
patent: 05331168 (1992-05-01), None
patent: 06206872 (1993-10-01), None
patent: WO 94/07865 (1994-04-01), None
patent: WO 99/18941 (1999-04-01), None
patent: 02/010137 (2002-02-01), None
patent: 02/051821 (2002-07-01), None
patent: 02/083648 (2002-10-01), None
patent: 03/050095 (2003-06-01), None
patent: 03/051860 (2003-06-01), None
patent: 04/000817 (2003-12-01), None
File REGISTRY on STN, Registry No. 328279-69-2, Mar. 21, 2001.
Stadlbauer, W., Product class 2: 1H- and 2H-indazoles, Science of Synthesis (2002), 12, 227-324.
Krishnan et al., Reactions of hydroxybenzophenone with hydrozines, Journal of Heterocyclic Chemistry (1988), 25(2), 447-52.
Cecil Textbook of Medicine, 20th edition (1996), vol. 2, pp. 2050-2057.
Cecil Textbook of Medicine, 20th edition (1996), vol. 2, pp. 1992-1996.
FDA mulls during to slow late-stage Alzheimer's [online], [retrieved on Sep. 23, 2003]. Retrieved from the Internet,URL;http://www.cnn.com/2003/HEALTH/conditions/09/24/alzheimers.drug.ap/index.html>.
Nathan, L., et al., Circulation Research, pp. 377-385, Aug. 20, 1999.
Grodstein, F., eta l., Annals of Internal Medicine, vol. 133, No. 12, pp. 933-941, Dec. 19, 2000.
Grodstein, F., et al., Annals of Internal Medicine, vol. 135, No. 1, pp. 1-8, Jul. 3, 2001.
Schonknecht, P., et al., Neuroscience Letters, 307, 2001, pp. 122-124.
Hulley, S., et al., JAMA, vol. 280, No. 7, Aug. 19, 1998, pp. 605-613.
Yuan, M., et al., Science, vol. 293, pp. 1673-1677, Aug. 31, 2001.
Pelletier, J-P., et al., Arthritis & Rheumatism, vol. 44, No. 6, pp. 1237-1247, Jun. 2001.
Collot, V., et al., Tetrahedron, 55, pp. 6917-6922, 1999.
Collot, V., et al., Tetrahedron Letters, 41, pp. 4363-4366, 2000.
Collot, V., et al., Tetrahedron Letters, 41, pp. 9053-9057, 2000.
Patel, M., et al., Bioorganic & Medicinal Chemistry Letters, 9, pp. 3217-3220, 1999.
Huang, J., et al., J. Am. Chem. Soc., 121, pp. 9889-9890, 1999.
Rodriguez, M.J., et al., Bioorganic & Medicinal Chemistry Letters, 9, pp. 1863-1868, 1999.
Roth, A., Journal of Neuroscience Research, 57, pp. 399-404, 1999.
Kurebayashi, S., et al., J. Steroid Biochem. Molec., Biol., vol. 60, No. 1-2, pp. 11-17, 1997.
Shutske, G. M. et al., “Heterocyclic oxyacetic acid diuretics: indazole, benzisothiazole, and benzisothiazole 1,1-dioxide analogs of [[7-chloro-3-(2-fluorophenyl)-1,2-benzisoxazol-6-yl]oxy]acetic acid,”J Med Chem, 1983, 26(9), 1307-11.

Affiliated with

Also associated with

Rating

Substituted 4-(indazol-3-yl)phenols does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted 4-(indazol-3-yl)phenols, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 4-(indazol-3-yl)phenols will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3812533